Albert S. DeNittis, MD

Accepting new patients
Headshot of Albert S. DeNittis, MD

Dr. DeNittis treats a variety of cancers, with a focus on cancers of the colon, rectum, lung, prostate, and skin as well as gynecologic and noncolorectal GI cancers and brain metastases. He has significant expertise in the use of advanced LINAC-based radiation therapy techniques and brachytherapy. Dr. DeNittis is actively involved in cancer clinical research and is the NRG Oncology principal investigator for Main Line Health. A graduate of University of Medicine and Dentistry of New Jersey, Dr. DeNittis completed a radiation oncology residency at Hospital of the University of Pennsylvania.

View Provider Bio
Radiation Oncology
Primary Practice:
Main Line Radiation Oncology
View all providers within this practice
Patient Reviews:


  1. 1
    100 East Lancaster Avenue
    Lankenau Medical Center, Cancer Center
    Wynnewood, PA 19096
  2. 2
    1078 West Baltimore Pike
    Radiation Oncology Center at Riddle Hosp, HC 1/Ground FL
    Media, PA 19063

Provider Bio

Albert S. DeNittis, MD

Albert S. DeNittis MD, MS, joined Main Line Health in 2002. He obtained his Master's degree in cellular and developmental biology at Rutgers University. Dr. DeNittis earned his medical degree from Rutgers-Robert Wood Johnson Medical School and completed his residency training in radiation oncology at the Hospital of the University of Pennsylvania. His primary specialties include rectal cancer, prostate cancer, gynecologic cancer, lung cancer, brain cancer and skin cancer. His primary treatments include intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and brachytherapy. The Radiation Oncology department at Lankenau Medical Center has been at the forefront of technological innovations, including the state-of-the-art linear accelerator, TrueBeam STx®. This advanced technology utilizing stereotactic body radiotherapy (SBRT) and volumetric modulated arc therapy (VMAT), allows for treatment to be completed in just three to five days. Dr. DeNittis serves on several national committees through NRG Oncology. He also serves on the National Cancer Institute Community Oncology Research Program (NCORP) steering, cancer prevention and control, and membership committees. In 2017, he was elected to the anal/rectal task force of the National Cancer Institute (NCI). He is responsible for clinical trial development nationally. His efforts have led to anextensive list of publications, and more than 100 presentations at national meetings. He has coauthored many book chapters, four of which have appeared in Principles and Practice of Radiation Oncology, the specialty's premier textbook. Though his achievements, he has earned the title of clinical professor at Lankenau Institute for Medical Research and membership in Thomas Jefferson University Cancer Center. He is a fellow of the College of Physicians of Philadelphia, has been listed as a Top Doc in Philadelphia magazine for several years. Dr. DeNittis is a Philadelphia Eagles' season ticket-holder and loves to spend time at the Jersey shore.

View Research Profile for Albert S. DeNittis, MD.

Years Experience:
*Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital. Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.

Education & Training


Awards & Memberships

Academic Titles

Patient Reviews